<DOC>
	<DOCNO>NCT01500668</DOCNO>
	<brief_summary>Patients intensive care unit ( ICU ) often require blood pressure support vasoactive drug amine . Finger necrosis ( call `` blue toe syndrome '' ) well document phenomena incidence reach high 60 % patient receive vasopressin . Botulinum toxin know muscle relaxant use variety medical application . Recently , several report demonstrate effect vasospastic disorder . It also mice administer locally local vasodilatory effect . The goal experiment compare effect Botulinum Toxin administer locally amine induce finger necrosis .</brief_summary>
	<brief_title>Botulinum Toxin A Treatment Catocholamine Induced Finger Necrosis</brief_title>
	<detailed_description />
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients treat vasoactive drug ( amine ) finger/toe necrosis Sensitivity drug ( Botox ) ingredient . Active local limb infection ICU admission due botulism Chronic muscular weakness disease , e.g. , Myasthenia gravis , ALS Age low 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Botox</keyword>
	<keyword>catocholamine</keyword>
	<keyword>shock</keyword>
	<keyword>vasomotor</keyword>
	<keyword>Vasopressin</keyword>
	<keyword>botulinum toxin</keyword>
</DOC>